[Corrigendum] Silibinin inhibits the migration and invasion of human gastric cancer SGC7901 cells by downregulating MMP‑2 and MMP‑9 expression via the p38MAPK signaling pathway
- Authors:
- Published online on: October 17, 2024 https://doi.org/10.3892/ol.2024.14753
- Article Number: 7
-
Copyright : © Lu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Article
Subsequently to the publication of the above paper and a Corrigendum that has already been published (doi./10.3892/ol.2021.12676) to address the issue of data that had been duplicated in Figs. 1, 2 and 4, it has come to light that there was a further data panel in Fig. 4C that was overlapping with the published version of Fig. 2C that was not included in that corrigendum. The fully corrected version of Fig. 4, now showing the corrected data for the ‘+Silibinin, ‑SB203580’ experiment in Fig. 4C (second panel on the left), is shown below. The authors regret that this additional error was not included in the original corrigendum, and apologize to the Editor of Oncology Letters and to the readership for the additional inconvenience caused. [Oncology Letters 14: 7577‑7582, 2017; DOI: 10.3892/ol.2017.7080]
